FDA Drug Shortage Database
Rocuronium (Zemuron) shortage
The FDA Drug Shortage Database lists 3 of 26 rocuronium presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on February 15, 2023. 23 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 10mg/1ml injection | 2 | 12 | 0 |
| 50mg/5ml injection | 0 | 6 | 0 |
| 100mg/10ml injection | 1 | 5 | 0 |
Which presentations are listed?
Limited or unavailable now (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Fresenius Kabi USA, LLC | Current posted February 15, 2023, updated September 15, 2026 | Unavailable; Delay in shipping of the drug |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Fresenius Kabi USA, LLC | Current posted February 15, 2023, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) | Piramal Critical Care Inc. | Current posted February 15, 2023, updated September 15, 2026 | Limited Availability; Demand increase for the drug |
Listed now, available (23)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Hikma Pharmaceuticals USA, Inc. | Current posted February 15, 2023, updated September 18, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Hikma Pharmaceuticals USA, Inc. | Current posted February 15, 2023, updated September 18, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Sandoz Inc. | Current posted February 15, 2023, updated September 18, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Sandoz Inc. | Current posted February 15, 2023, updated September 18, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Sagent Pharmaceuticals | Current posted February 15, 2023, updated September 18, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Fresenius Kabi USA, LLC | Current posted February 15, 2023, updated October 6, 2026 | Available; Requirements related to complying with good manufacturing practices |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Fresenius Kabi USA, LLC | Current posted February 15, 2023, updated September 15, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Fresenius Kabi USA, LLC | Current posted February 15, 2023, updated September 15, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Mylan Institutional, a Viatris Company | Current posted February 15, 2023, updated October 5, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Mylan Institutional, a Viatris Company | Current posted February 15, 2023, updated October 5, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) | Meitheal Pharmaceuticals, Inc. | Current posted February 15, 2023, updated August 27, 2026 | Available |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) | Meitheal Pharmaceuticals, Inc. | Current posted February 15, 2023, updated August 27, 2026 | Available |
| Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Hospira, Inc., a Pfizer Company | Current posted February 15, 2023, updated September 22, 2026 | Available |
| Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Hospira, Inc., a Pfizer Company | Current posted February 15, 2023, updated September 22, 2026 | Available |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | XGen Pharmaceuticals DJB, Inc. | Current posted February 15, 2023, updated September 22, 2026 | Available |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Baxter Healthcare | Current posted February 15, 2023, updated October 2, 2026 | Available |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Eugia US LLC | Current posted February 15, 2023, updated October 2, 2026 | Available |
| Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Hospira, Inc., a Pfizer Company | Current posted February 15, 2023, updated September 22, 2026 | Available |
| Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Hospira, Inc., a Pfizer Company | Current posted February 15, 2023, updated September 22, 2026 | Available |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | XGen Pharmaceuticals DJB, Inc. | Current posted February 15, 2023, updated September 22, 2026 | Available |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Baxter Healthcare | Current posted February 15, 2023, updated October 2, 2026 | Available |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Eugia US LLC | Current posted February 15, 2023, updated October 2, 2026 | Available |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Piramal Critical Care Inc. | Current posted February 15, 2023, updated September 15, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage